X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Journal of the National Comprehensive Cancer Network

期刊標題檢索 J NATL COMPR CA 最新評論: Please translate the following paragraph into English and Japanese, a... (2024-02-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Journal of the National Comprehensive Cancer Network]您好,您是該頁面的第 19692 位訪客。

期刊簡介
期刊名稱Journal of the National Comprehensive Cancer Network Journal of the National Comprehensive Cancer Network
LetPub Score
8.7
50 ratings
Rate

Reputation
10.0

Influence
8.0

Speed
7.0

期刊簡稱J NATL COMPR CANC NE
ISSN1540-1405
E-ISSN1540-1413
h-index88
CiteScore
CiteScoreSJRSNIPCiteScore Rank
20.204.1024.384
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q120 / 404

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology®, (solicited) review articles elaborating on guideline recommendations, health services research, and case reports highlighting molecular insights in patient care.

JNCCN's vision is to further the mission of NCCN by serving as the primary resource for information on NCCN Clinical Practice Guidelines (NCCN Guidelines®), innovation in translational medicine, and on scientific studies related to oncology health services research, including quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship.
官方網站http://www.jnccn.org/
在線稿件提交http://www.editorialmanager.com/jnccn/default.aspx
開放訪問No
出版商Cold Spring Publishing LLC
主題領域ONCOLOGY
出版國/地區UNITED STATES
發行頻率月刊
創刊年2003
每年文章數141每年文章數趨勢
黃金OA百分比0.64%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ116/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1540-1405%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Journal of the National Comprehensive Cancer Network】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE643792
    BIOMATERIALS595076
    BIOMEDICINE & PHARMACOTHERAPY498526
    Frontiers in Pharmacology498240
    JOURNAL OF ETHNOPHARMACOLOGY488002
    Journal of Materials Chemistry B476121
    Frontiers in Immunology460312
    COLLOIDS AND SURFACES B-BIOINTERFACES419398
    COMPUTERS IN BIOLOGY AND MEDICINE418387
    Frontiers in Oncology415018
  •  

    Journal of the National Comprehensive Cancer Network Journal of the National Comprehensive Cancer Network
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Journal of the National Comprehensive Cancer Network] 的評論撰寫評論
作者: 般若尔青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-02 08:16:30 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as the headings
(0) 讚! | 般若尔青

作者: Judith Acheson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-25 20:56:12 評論於
Do authors need to fill out a confirmation email after submission? I have been stuck at "Received/Under Preliminary Consideration" since submission, and it's been almost 2 weeks. Could it be that the editors haven't processed it yet?
(0) 讚! | Judith Acheson

作者: 降龙树芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-26 17:23:29 評論於
Received/Under Preliminary Consideration for 13 days, not sure what the situation is
(0) 讚! | 降龙树芬

作者: 降龙树芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-25 14:19:15 評論於
Share your experience of submitting articles
(0) 讚! | 降龙树芬

作者: 孤云诗儿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-15 15:29:12 評論於
3.31 Submitted
6.08 First revision returned
6.25 First revision resubmitted
8.14 Second revision
8.14 10:40 PM, Reviewer requested deletion of a few extra images
8.15 5 AM Article accepted
(0) 讚! | 孤云诗儿

作者: 孤云诗儿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-14 15:53:16 評論於
Research focus: Queue studies; Sharing of clinical oncology research experience: Accepted after 4 months
(0) 讚! | 孤云诗儿

作者: Bruno Zechariah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-25 08:54:38 評論於
Awesome, just submitted an article and it's been 6 days and still in the initial editing stage
(0) 讚! | Bruno Zechariah

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 19:07:46 評論於
Master!
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 13:20:17 評論於
Amazing, that was fast!
(0) 讚! | 是志丹吖

作者: 芝英baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-23 08:17:16 評論於
Research Focus: Gastric Cancer Experience Sharing: Received/Under Preliminary Consideration for 6 days, Under Consideration for 1 day, Under Review for 1 day, not sure if it has been sent out for external review or still in the hands of the editor, anxiously waiting
(0) 讚! | 芝英baby

作者: 库里蒂斯哈特


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-16 10:14:26 評論於
Awesome
(0) 讚! | 库里蒂斯哈特

作者: 穿心情韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-09 17:22:47 評論於
Masterfully skilled
(0) 讚! | 穿心情韵

作者: 千斤阳曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-27 20:12:22 評論於
Review Speed: 1.0 | Submission Hit Rate: 25.0 Emphasis on Research Areas: Clinical Oncology Research; Experience Sharing on Cohort Studies: The official journal of NCCN guidelines, a highly authoritative publication in the field of oncology with a high citation rate. As long as the idea is new enough to slightly improve the existing guideline recommendations, rapid publication can be achieved. It takes less than 2 months from submission to acceptance, with no page charges, but acceptance to online publication generally takes about half a year. Thanks to the efficient work of the editors!
(0) 讚! | 千斤阳曦

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:57:00 評論於
A research article is a main type of research paper published in journals, typically longer in length with a large amount of research data. Compared to other types of articles, if it is basic research, the chain of evidence will be ample and complete
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:11:45 評論於
Protocol is a type of research article published in journals, typically reviews or comments by experts in the field on certain hot topics or new research findings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 14:44:02 評論於
What is Protocol?
(0) 讚! | 魂魄彦露

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:56:20 評論於
What is the difference between a research article and other types of articles?
(0) 讚! | 陶宜三岁啦

作者: 穿心情韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-27 19:53:46 評論於
How long did it take for you to be rejected when you were under consideration?
(0) 讚! | 穿心情韵

作者: 穿心情韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-27 16:59:27 評論於
How long were you Under Consideration at that time?
(0) 讚! | 穿心情韵

作者: 穿心情韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-26 19:40:38 評論於
This magazine is really mysterious. I submitted an article in September and got rejected in 20 days. First, it was "Received/Under Preliminary Consideration" for 14 days, and then "Under Consideration" for 7 days. Such a delay!
(0) 讚! | 穿心情韵

作者: 暗月寺奕卓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-06 13:54:55 評論於
How did it end in the end?
(0) 讚! | 暗月寺奕卓

作者: 穿心情韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-18 16:23:38 評論於
How is the status behind you? Does "Under Consideration" mean it's being sent for external review?
(0) 讚! | 穿心情韵

作者: 穿心情韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-18 11:43:37 評論於
How are you doing, OP?
(0) 讚! | 穿心情韵

作者: 利强小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-13 23:06:54 評論於
Has it been sent for external review?
(0) 讚! | 利强小仙女

作者: 利强小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-13 14:18:17 評論於
Has "Under consideration" been sent for external review?
(0) 讚! | 利强小仙女

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Journal of the National Comprehensive Cancer Network] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*